Please login to the form below
antiviral treatments
This page shows the latest antiviral treatments news and features for those working in and with pharma, biotech and healthcare.
National trial to rapidly find treatments for severe flu this winter launched in UK
REMAP-CAP will test multiple treatments at the same time in thousands of people. ... We hope that our trial will help to find urgently needed flu treatments rapidly.
Latest news
-
WHO reports warnings of ‘COVID-19 complacency’ from countries tracking global vaccine roll-out
lifesaving’ COVID-19 treatments including oral antivirals in low- and lower-middle income countries remains 'limited or non-existent'. ... are still unvaccinated and do not have access to new antiviral treatments.
-
Pfizer to supply 6 million Paxlovid treatments to low- and middle-income countries
19 tests, treatments, personal protective equipment and critical elements of ‘health systems strengthening’. ... The company also outlined its plans to provide product donation and funding to the COVID Treatment Quick Start Consortium, launched on 7
-
UK government invests £175m to ‘supercharge’ clinical research
Benefits have already been seen from this digital approach, such as in the delivery of antiviral treatments to protect vulnerable people from COVID-19. ... As a global life sciences superpower, we have led the world on vaccines and antiviral treatments
-
Pandemic Antiviral Discovery initiative created by the Novo Nordisk Foundation, Open Philanthropy and the Gates Foundation
The initial RFP is scheduled to be announced during the International Conference on Antiviral Research (ICAR) in Seattle, Washington. ... By doing this, PAD hopes to be able to quickly develop and equitably distribute effective, accessible antiviral
-
US regulators set to approve oral antiviral against COVID-19
The FDA looks set to authorise Merck’s molnupiravir after its advisory body recommended the antiviral treatment, while Pfizer’s Paxlovid may be next. ... Oral antiviral treatments that combat the worst effects of COVID-19 are under the regulatory
More from news
Approximately 2 fully matching, plus 15 partially matching documents found.
Subscribe to our email news alerts
- Roche to acquire Carmot Therapeutics in deal worth up to $3.1bn
- Eli Lilly’s Jaypirca granted FDA accelerated approval for non-Hodgkin lymphomas
- UK-India research project trialling easy-to-use UTI test to support fight against AMR
- Cancer Research UK and Guardant collaborate to advance cancer detection and treatment
- Give the gift of positive change
- Apple Vision Pro: challenges and opportunities for pharma
No results were found
PMHub
Langland
Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
